Physician profile
Ann E Eggert
NPI 1083605281
$789.79
in general payments reported to CMS, 2019-2025
10 companies · $221 in 2025
The $221 reported for 2025 was more than what 77% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.57 · 2020: $22.09 · 2021: $39.07 · 2022: $118 · 2023: $117 · 2024: $180 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $313.73 | 2023-2025 | Qelbree, Qelbree |
| Cranial Technologies, INC | $153.62 | 2019-2024 | Doc Band |
| Ironshore Pharmaceuticals INC. | $85.40 | 2022-2023 | Jornay Pm |
| Pfizer INC. | $78.70 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $57.26 | 2021-2023 | Vaxneuvance, Gardasil 9, Rotateq |
| Corium, LLC | $32.98 | 2024 | Azstarys |
| Sanofi Pasteur INC. | $18.55 | 2025 | |
| Aimmune Therapeutics, INC. | $18.42 | 2023 | |
| Tris Pharma INC | $18.10 | 2019 | |
| Phadia US INC. | $13.03 | 2023 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Eggert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.